Caillé G - Search Results

1

Effect of oral ondansetron on total cholecystokinin plasma levels following CCK-4 panic challenge procedure in healthy men.

Dépôt M, Merani S, Bradwejn J, Mukherjee J, Caillé J, Gutkowska J, Caillé G. Dépôt M, et al. Among authors: caille g. J Psychiatry Neurosci. 1998 Nov;23(5):298-304. J Psychiatry Neurosci. 1998. PMID: 9846035 Free PMC article. Clinical Trial.

2

Acute and chronic role of 5-HT3 neuronal system on behavioral and neuroendocrine changes induced by intravenous cholecystokinin tetrapeptide administration in humans.

Dépôt M, Caillé G, Mukherjee J, Katzman MA, Cadieux A, Bradwejn J. Dépôt M, et al. Among authors: caille g. Neuropsychopharmacology. 1999 Feb;20(2):177-87. doi: 10.1016/S0893-133X(98)00074-8. Neuropsychopharmacology. 1999. PMID: 9885797 Clinical Trial.

3

High-resolution liquid chromatographic method using ultraviolet detection for determination of ondansetron in human plasma.

Dépôt M, Leroux S, Caillé G. Dépôt M, et al. Among authors: caille g. J Chromatogr B Biomed Sci Appl. 1997 Jun 6;693(2):399-406. doi: 10.1016/s0378-4347(97)00068-6. J Chromatogr B Biomed Sci Appl. 1997. PMID: 9210445

4

Lack of presystemic metabolism of nifedipine in the rabbit.

du Souich P, Héroux L, Maurice H, Dépôt M, Caillé G. du Souich P, et al. Among authors: caille g. J Pharmacokinet Biopharm. 1995 Dec;23(6):567-80. doi: 10.1007/BF02353462. J Pharmacokinet Biopharm. 1995. PMID: 8733947

5

Pharmacokinetics of oral diltiazem and five of its metabolites in patients with chronic renal failure.

Tawashi M, Marc-Aurèle J, Bichet D, Spénard J, Larivière L, Plante D, Caillé G. Tawashi M, et al. Among authors: caille g. Biopharm Drug Dispos. 1991 Mar;12(2):95-104. doi: 10.1002/bdd.2510120202. Biopharm Drug Dispos. 1991. PMID: 2031997

6

Nonlinear kinetics and pharmacologic response to mibefradil.

du Souich P, Besner JG, Clozel JP, Welker HA, Lefebvre M, Caillé G. du Souich P, et al. Among authors: caille g. Clin Pharmacol Ther. 2000 Mar;67(3):249-57. doi: 10.1067/mcp.2000.104616. Clin Pharmacol Ther. 2000. PMID: 10741628 Clinical Trial.

7

Placebo-controlled comparative study of the anxiolytic activity and of the pharmacokinetics of oral and sublingual lorazepam in generalized anxiety.

Spénard J, Caillé G, de Montigny C, Vézina M, Ouellette J, Larivière L, Trudel F. Spénard J, et al. Among authors: caille g. Biopharm Drug Dispos. 1988 Sep-Oct;9(5):457-64. doi: 10.1002/bod.2510090504. Biopharm Drug Dispos. 1988. PMID: 3066417 Clinical Trial.

8

Comparative pharmacokinetics and pharmacodynamics of two marketed bid formulations of diltiazem in healthy volunteers.

Guimont S, Landriault H, Klischer K, Grace M, Lambert C, Caillé G, Gossard D, Russell A, Raymond M, Hutchings E, et al. Guimont S, et al. Among authors: caille g. Biopharm Drug Dispos. 1993 Dec;14(9):767-78. doi: 10.1002/bdd.2510140903. Biopharm Drug Dispos. 1993. PMID: 8298070 Clinical Trial.

9

Influence of food on the bioavailability of diltiazem and two of its metabolites following the administration of conventional tablets and slow-release capsules.

Du Souich P, Lery N, Lery L, Varin F, Boucher S, Vezina M, Pilon D, Spenard J, Caillé G. Du Souich P, et al. Among authors: caille g. Biopharm Drug Dispos. 1990 Mar;11(2):137-47. doi: 10.1002/bdd.2510110206. Biopharm Drug Dispos. 1990. PMID: 2328299 Clinical Trial.

10

Effects of food and sucralfate on the pharmacokinetics of naproxen and ketoprofen in humans.

Caillé G, du Souich P, Besner JG, Gervais P, Vézina M. Caillé G, et al. Am J Med. 1989 Jun 9;86(6A):38-44. doi: 10.1016/0002-9343(89)90155-1. Am J Med. 1989. PMID: 2735334 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters